WPI 3659 (Desvenlafaxine Succinate Extended-Release 50 mg (base))
Pill with imprint WPI 3659 is Pink, Four-sided and has been identified as Desvenlafaxine succinate extended-release 50 mg (base). It is supplied by Actavis Pharma, Inc..
Desvenlafaxine is used in the treatment of major depressive disorder; depression; anxiety; adhd; bipolar disorder (and more), and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Desvenlafaxine 50 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 3659
Desvenlafaxine succinate extended-release
- Imprint:
- WPI 3659
- Strength:
- 50 mg (base)
- Color:
- Pink
- Shape:
- Four-sided
- Availability:
- Prescription only
- Drug Class:
- Serotonin-norepinephrine reuptake inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Actavis Pharma, Inc.
- National Drug Code (NDC):
- 00591-3659
More about desvenlafaxine
- Desvenlafaxine Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 918 Reviews
- Drug class: serotonin-norepinephrine reuptake inhibitors
Consumer resources
Other brands: Pristiq, Khedezla
Professional resources
- Desvenlafaxine Succinate (AHFS Monograph)
- Desvenlafaxine ER Tablets (FDA)
- Desvenlafaxine (Wolters Kluwer)
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
